Genovis AB (publ.) (GENO) — Capital Reinvestment Ratio
Latest as of December 2025:
1.00x
Genovis AB (publ.) (GENO) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr15.90 Million) in capital expenditures (Skr15.90 Million). See GENO cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.00x
Capex / Operating Cash Flow
Operating Cash Flow
Skr15.90 Million
SEK
Capital Expenditures
Skr15.90 Million
SEK
Data as of
Dec 2025
Most recent filing
Genovis AB (publ.) Capital Reinvestment Ratio (2019–2025)
This chart tracks Genovis AB (publ.)'s Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Genovis AB (publ.) (2019–2025)
Year-by-year Capital Reinvestment Ratio for Genovis AB (publ.) from 2019 to 2025. For live market cap and broader valuation context, see Genovis AB (publ.) stock valuation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr32.02 Million | Skr32.02 Million | ▲ +3314.5% |
| 2024 | 0.03x | Skr37.12 Million | Skr1.09 Million | ▼ -84.5% |
| 2023 | 0.19x | Skr67.75 Million | Skr12.81 Million | ▲ +93.3% |
| 2021 | 0.10x | Skr45.92 Million | Skr4.49 Million | ▼ -98.2% |
| 2020 | 5.44x | Skr3.76 Million | Skr20.43 Million | ▲ +1285.5% |
| 2019 | 0.39x | Skr13.13 Million | Skr5.15 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow